KGaA Merck
CIK 1764133 · last filed 2021-10-26
KGaA Merck is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for XLO, was dated Oct 26, 2021. Current disclosed insider exposure totals $437.7K across reported positions. 2 SEC filings were submitted jointly with Ares Trading S.A.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$437.7K
1
1
$0
Filer Profile
DARMSTADT, 2M 64293
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XLO | 10%+ Owner | 48,630 | $9.00 | $437.7K | $0 | 1 | 2021-10-26 |
Recent Filings
1 filingNotice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.